company background image
PSH logo

Sernova DB:PSH Stock Report

Last Price

€0.15

Market Cap

€48.0m

7D

1.1%

1Y

-68.0%

Updated

25 Dec, 2024

Data

Company Financials +

My Notes

Capture your thoughts, links and company narrative

Sernova Corp. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Sernova
Historical stock prices
Current Share PriceCA$0.15
52 Week HighCA$0.49
52 Week LowCA$0.13
Beta1.23
1 Month Change-2.02%
3 Month Change-1.63%
1 Year Change-67.98%
3 Year Change-88.23%
5 Year Change25.58%
Change since IPO10.81%

Recent News & Updates

Recent updates

Shareholder Returns

PSHDE BiotechsDE Market
7D1.1%-0.8%-1.6%
1Y-68.0%-13.0%6.8%

Return vs Industry: PSH underperformed the German Biotechs industry which returned -13.2% over the past year.

Return vs Market: PSH underperformed the German Market which returned 6.8% over the past year.

Price Volatility

Is PSH's price volatile compared to industry and market?
PSH volatility
PSH Average Weekly Movement13.4%
Biotechs Industry Average Movement6.9%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.6%
10% least volatile stocks in DE Market2.4%

Stable Share Price: PSH's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: PSH's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
1998n/aJonathan M. Rigbywww.sernova.com

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection. Its Cell Pouch is a novel implantable and scalable medical device which forms a natural environment in the body for the housing and long-term survival and function of therapeutic cells, which release necessary proteins or factors missing from the body to treat chronic diseases as an alternative to daily administration of drugs.

Sernova Corp. Fundamentals Summary

How do Sernova's earnings and revenue compare to its market cap?
PSH fundamental statistics
Market cap€47.97m
Earnings (TTM)-€21.58m
Revenue (TTM)n/a

0.0x

P/S Ratio

-2.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PSH income statement (TTM)
RevenueCA$0
Cost of RevenueCA$0
Gross ProfitCA$0
Other ExpensesCA$32.19m
Earnings-CA$32.19m

Last Reported Earnings

Oct 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.099
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did PSH perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 17:16
End of Day Share Price 2024/12/23 00:00
Earnings2024/10/31
Annual Earnings2024/10/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sernova Corp. is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Christian OrqueraFirst Berlin Equity Research GmbH
Joseph PantginisH.C. Wainwright & Co.
Chelsea StellickiA Capital Markets